Related references
Note: Only part of the references are listed.A Randomized, Placebo-Controlled Trial of Latrepirdine in Huntington Disease
Karl Kieburtz et al.
ARCHIVES OF NEUROLOGY (2010)
SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease
Pablo Garcia-Reitboeck et al.
BRAIN (2010)
Discovery of a Proneurogenic, Neuroprotective Chemical
Andrew A. Pieper et al.
CELL (2010)
Cognition-Enhancing Properties of Dimebon in a Rat Novel Object Recognition Task Are Unlikely to Be Associated with Acetylcholinesterase Inhibition or N-Methyl-D-aspartate Receptor Antagonism
Marco Giorgetti et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Absence of α-synuclein affects dopamine metabolism and synaptic markers in the striatum of aging mice
Abdelmojib Al-Wandi et al.
NEUROBIOLOGY OF AGING (2010)
Methylene blue and dimebon inhibit aggregation of TDP-43 in cellular models
Makiko Yamashita et al.
FEBS LETTERS (2009)
γ-Synucleinopathy: neurodegeneration associated with overexpression of the mouse protein
Natalia Ninkina et al.
HUMAN MOLECULAR GENETICS (2009)
Liquid chromatography-tandem mass spectrometry method for the quantification of dimebon in rat plasma and brain tissue
Ramakrishna Nirogi et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2009)
Acute dosing of latrepirdine (Dimebon™), a possible Alzheimer therapeutic, elevates extracellular amyloid-β levels in vitro and in vivo
John W. Steele et al.
MOLECULAR NEURODEGENERATION (2009)
Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study
Rachelle S. Doody et al.
LANCET (2008)
Evaluation of Dimebon in cellular model of Huntington's disease
Jun Wu et al.
MOLECULAR NEURODEGENERATION (2008)
The effect of truncated human alpha-synuclein (1-120) on dopaminergic cells in a transgenic mouse model of Parkinson's Disease
A. W. Michell et al.
CELL TRANSPLANTATION (2007)
Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human α-synuclein (1-120):: Implications for Lewy body disorders
GK Tofaris et al.
JOURNAL OF NEUROSCIENCE (2006)
Olfaction and Parkinson's syndromes: its role in differential diagnosis
R Katzenschlager et al.
CURRENT OPINION IN NEUROLOGY (2004)
Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of γ-synuclein, α-synuclein and double α/γ-synuclein null mutant mice
DC Robertson et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Comparative study of action mechanisms of dimebon and memantine on AMPA- and NMDA-subtypes glutamate receptors in rat cerebral neurons
VV Grigor'ev et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2003)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Deletion of the alpha-synuclein locus in a subpopulation of C57BL/6J inbred mice
Christian G. Specht et al.
BMC NEUROSCIENCE (2001)
Share Paper
